← All organizations
Highest phase reached
Phase 3
First clinical trial
May 17, 2018Last known activity
Sep 1, 2023
Timeline
1970s
- Jun 1, 1973
Prodia StemCell Indonesia— Founded
Drugs by trial phase (4 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT05909488Lead sponsorPhase 2/Phase 3Sep 1, 2023
- NCT05909488OfficialPhase 2/Phase 3Sep 1, 2023
- NCT05909488Study chairPhase 2/Phase 3Sep 1, 2023
- NCT05935423CollaboratorPhase 3Jul 31, 2023
- NCT05279768Lead sponsorPhase 1/Phase 2Sep 1, 2022
- NCT05279768Study chairPhase 1/Phase 2Sep 1, 2022
- NCT05261750Lead sponsorPhase 1/Phase 2Apr 30, 2022
- NCT05261750Study chairPhase 1/Phase 2Apr 30, 2022
- NCT05008588Lead sponsorPhase 1/Phase 2Sep 30, 2021
- NCT04326959Lead sponsorPhase 1/Phase 2Jun 1, 2020
- NCT04314661Lead sponsorPhase 1/Phase 2Apr 8, 2020
- NCT04314687Lead sponsorPhase 1/Phase 2Mar 25, 2020
- NCT04340609Lead sponsorPhase 1/Phase 2Mar 11, 2019
- NCT04315025Study chairPhase 1/Phase 2Oct 7, 2018
- NCT04315025Lead sponsorPhase 1/Phase 2Oct 7, 2018
Details
- Founded
- jakarta, ID Jun 1, 1973
- Last known activity
- Sep 1, 2023